-- Sunshine Guojian Pharmaceutical Shanghai (SHA:688336) posted first-quarter attributable net profit of 178.1 million yuan, up 73% from 103.0 million yuan the previous year.
Earnings per share rose to 0.29 yuan from 0.17 yuan, according to a weekend filing with the Shanghai bourse.
Operating revenue climbed 39% year over year to 431.2 million yuan from 311.1 million yuan.
Shares of the drugmaker declined 3% in recent trade.